Adagio Medical Holdings, Inc. (ADGM)
NASDAQ: ADGM · Real-Time Price · USD
2.700
-0.170 (-5.92%)
Oct 31, 2024, 4:00 PM EDT - Market closed

Company Description

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias.

It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia.

The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories.

The company was founded in 2011 and is headquartered in Laguna Hills, California.

Adagio Medical Holdings, Inc.
Adagio Medical Holdings logo
Country United States
Founded 2011
Industry Medical Devices
Sector Healthcare
Employees 85
CEO Olav Bergheim

Contact Details

Address:
26051 Merit Circle, Suite 102
Laguna Hills, California 92653
United States
Phone 949-348-1188
Website adagiomedical.com

Stock Details

Ticker Symbol ADGM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0002006986
ISIN Number US00534B1008
SIC Code 3841

Key Executives

Name Position
Olav B. Bergheim President, Chief Executive Officer, Secretary and Executive Director
John T. Dahldorf Chief Financial Officer
Hakon Bergheim Chief Operating Officer
Dr. Alex Babkin Ph.D. Chief Technical Officer
Nabil Jubran Chief Compliance Officer
Ilya Grigorov Vice President of Global Marketing and Product Management
Tim Glynn Vice President of Global Sales

Latest SEC Filings

Date Type Title
Oct 8, 2024 S-8 Securities to be offered to employees in employee benefit plans
Sep 19, 2024 EFFECT Notice of Effectiveness
Sep 19, 2024 EFFECT Notice of Effectiveness
Sep 19, 2024 424B3 Prospectus
Sep 19, 2024 424B3 Prospectus
Sep 17, 2024 UPLOAD Filing
Sep 17, 2024 UPLOAD Filing
Sep 13, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Sep 13, 2024 S-1 General form for registration of securities under the Securities Act of 1933
Aug 26, 2024 10-Q Quarterly Report